Finance Business Partner - CTO Cluster

Good Health Can’t Wait

We started in 1984 with a modest investment, 20 employees and a bold vision. Today, we have research and development centres, manufacturing facilities or a commercial presence in 66 countries.

For nearly four decades, we have stood for access, affordability and innovation based on the bedrock of deep science, progressive people practices and robust corporate governance. As the pharmaceutical industry evolves and undergoes disruption, we see an opportunity – to strengthen our core further (the next steps) and to build the future (the new bets).

‘The Next and the New’ is how we aim to continue to be the partner of choice – purpose-driven, future-ready and sustainable. Our aim is to reach over 1.5 Bn+ patients across the world by 2030 by growing our core businesses and building for the future with sustainability at the core of our purpose and strategy. Sustainability for us means operating in a manner that respects people, planet and purpose – helping us conserve precious resources, serve our patients, create value for stakeholders, give back to society, fulfil our potential and maintain our integrity and transparency

Dr Reddy’s maintains a work environment, free from discrimination and is an equal opportunity employer. We are committed to employ & nurture all qualified diverse workforce without regard to race, colour religion, nationality, sex, age, disability status, genetics, sexual orientation, gender expression, citizenship or any other characteristic or classification protected by applicable law(s) of the country we operate in. We treasure every talent, and recognize merit and diversity in our organization.

Finance Business Partner shall closely work with Cluster Finance Head for CTO’s. Finance Analyst will be responsible for Overall Analytics for CTO’s using advanced analytics tools, Support in effectively driving the strategic initiatives including Monthly reviews, Quarterly reviews, Operational Excellence, Standardization efforts of Processes and Presentations. This role is also responsible to support in month end closure of Mexico entity.

Key Roles & Responsibilities:

Analytics:

1. Prepare and present dashboards of key metrics of Plant operations.
2. Support Cluster finance head in driving MRM’s and QRM’s and any other review meetings.
3. Align with Front end teams and generate insights on the Products and action plans to increase the profitability
4. Analytics of the cluster for any requirements of Leadership.

Governance:

1. Work closely with Plant teams and ensure MRM’s are conducted at every plant.
2. Prepare and Ensure that Cluster MRM’s and Cluster QRM’s conducted in timely manner.
3. Support Cluster Finance head in governance of Ideas generated in Operational Excellence. Work closely with plant teams and ensure all the activities are on track
4. Tracking of Key metrics for Plant score cards and provide the insights on plant performance

Controlling & Books closure Mexico entity:

1. Monthly Book closure of the Plant related activities & spends.
2. Scrutinize GL accounts & rectification entries to be posted, incase of any item found.
3. Review and provisioning of Pending GRNs.
4. Tracking and closure of overdue RGPs & pending STOs
5. Review and report exceptions in Plant relevant Balance Sheet GLs.
6. Ensure and sign-off of FSCP Documentation.

Budget & Latest Estimates:

1. Support Cluster Finance head in Annual Budgeting exercise and work closely with Plant Finance heads for individual Plant budgets.
2. Support in Cash OpEx budget, RMCs with TVC (yield and solvents) savings at cluster level.
3. Monthly basis provide Latest Estimates to FP&A Team and report the reasons for variances Vs Budget

Operational Excellence (OE)

1. Actively participate in discussions of OE Saving ideas generation and estimate the idea potential for generated ideas.
2. Review and Tracking of Cash OE, TVC & OVC Savings vs target.
3. Reporting of OE Savings status to all stakeholders.

Capex and Assets:

1. Participate and Co-Ordinate with Plant Finance head’s and support in Capex discussions at cluster Level and support on working for Capex evaluations.

Audits & Compliance

1. Meet the audit requirements like Statutory, SOX, and internal audits for the plant.
2. Co-ordinating for physical verification of inventory (stock audits) and discuss with WH teams and closure of variances between books and physical inventory as per guidelines.
3. Compliance with accounting policies and guidelines
   

Qualifications

Educational qualification

Additional Information

About the Department

Emerging Markets

Branded generics is one of our biggest businesses in Emerging market and our branded products are available 48 countries across 5 regions. Our key markets are Russia, China and Brazil. We also have presence in Latin America, Africa, Australia, New Zealand, ASEAN (Association of Southeast Asian Nations), CIS and Romania. We have added 13 new geographies in the last 5 years.

In the last 4 years, our emerging markets business’ growth rate has doubled (June ’22). Our diverse portfolio spans all segments. We are continuously advancing technologies, enhancing efficiency of operations and increasing our portfolio of highest-quality quality products.

With nearly 40 products and 6 mega brands, Russia is a key market. With more than 30 years of operations in the region, as of FY22, we have reported a year-on-year growth of 32%. This was driven by improved existing business performance, launch of new products during the year along with divestment of some non-core brands. 6 key products were ranked among the top 200 bestselling formulation brands, as per IQVIA in its report for the 12-month period ended 31 March, 2022. 5 of our leading products were voted as the ’Product of the Year’ by the consumers – reaffirming the trust that the people of Russia have in them.

We are among the earliest Indian pharma companies to have a business presence in China. We have a representative office that focuses on filings and approvals, including the Group Purchasing Organisation (GPO). Our joint venture entity (Kunshan Rotam Reddy Pharmaceutical Co. Ltd) offers a portfolio of niche and essential products, strengthening our presence in China.

In Latin America we have a strong presence in Brazil and Colombia. In just a little over five years in Brazil, our team has established itself in the region with our diverse portfolio. Our primary focus in Brazil is oncology and institutional. Our team in Colombia was certified as a ‘Great Place to Work’.

Through our comprehensive COVID-19 portfolio, we were able to reach over 5 million patients in low and middle-income countries. With the aim of reaching more and more patients around the world, we are harnessing our deep science capabilities to create a robust portfolio in the region to become the partner of choice.

Our teams in China, Brazil, Colombia and Thailand, Malaysia are a certified great place to work. Our team in Russia is among the top 3 in Head-hunter’s Best Employer Ranking in 2022. These recognitions reaffirm our commitment and efforts to bring science, technology and innovation together to offer affordable medicines and solutions beyond the pill to patients in the region.

Benefits Offered